サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1531029

レボチロキシン市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2034年

Levothyroxine Market (Route of Administration: Oral and Injectables; and End-user: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 167 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
レボチロキシン市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2034年
出版日: 2024年06月27日
発行: Transparency Market Research
ページ情報: 英文 167 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レボチロキシン市場- 調査範囲

TMRの調査レポート「レボチロキシンの世界市場」は、2024年から2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018年から2034年までの世界のレボチロキシン市場の収益と予測を提供しています。また、2024年から2034年までの世界のレボチロキシン市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、レボチロキシン市場を推察しました。

市場スナップショット
2023年の市場規模 38億米ドル
2034年の市場規模 54億米ドル
CAGR 3.3%

当レポートでは、世界のレボチロキシン市場の競合情勢について調査しています。世界のレボチロキシン市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTなどが、本レポートで紹介されている世界のレボチロキシン市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の市場分析と予測、2020年～2034年

第5章 主要洞察

  • パイプライン分析
  • 主要製品/ブランド分析
  • 主要M&A
  • COVID-19による産業への影響

第6章 世界の市場分析と予測：投与経路別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：投与経路別、2020年～2034年
    • オーラル
    • 注射剤
  • 市場の魅力分析：投与経路別

第7章 世界の市場分析と予測：流通チャネル別

  • イントロダクションと定義
  • 主な調査結果・発展
  • 市場金額予測：流通チャネル別、2020年～2034年
    • 病院薬局
    • 小売薬局
    • オンライン薬局
  • 市場の魅力分析：流通チャネル別

第8章 世界の市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2020年～2034年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域別

第9章 北米の市場分析と予測

第10章 欧州の市場分析と予測

第11章 アジア太平洋の市場分析と予測

第12章 ラテンアメリカの市場分析と予測

第13章 中東・アフリカの市場分析と予測

第14章 競合情勢

  • 市場企業- 競争マトリックス（企業階層と規模別）
  • 市場シェア分析：企業別（2023年）
  • 企業プロファイル
    • AbbVie Inc.
    • Mylan N.V.
    • Merck & Co., Inc.
    • Pfizer Inc.
    • Lannett Company Inc
    • Novartis AG
    • Fresenius Kabi
    • Piramal Critical Care
    • Abbott Laboratories
図表

List of Tables

  • Table 01: Global Levothyroxine Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 02: Global Levothyroxine Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 03: Global Levothyroxine Market Size (US$ Bn) Forecast, by Region, 2020-2034
  • Table 04: North America Levothyroxine Market Size (US$ Bn) Forecast, by Country, 2020-2034
  • Table 05: North America Levothyroxine Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 06: North America Levothyroxine Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 07: Europe Levothyroxine Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 08: Europe Levothyroxine Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 09: Europe Levothyroxine Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 10: Asia Pacific Levothyroxine Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 11: Asia Pacific Levothyroxine Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 12: Asia Pacific Levothyroxine Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 13: Latin America Levothyroxine Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 14: Latin America Levothyroxine Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 15: Latin America Levothyroxine Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 16: Middle East & Africa Levothyroxine Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Middle East & Africa Levothyroxine Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 18: Middle East & Africa Levothyroxine Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034

List of Figures

  • Figure 01: Global Levothyroxine Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034
  • Figure 02: Global Levothyroxine Market Revenue (US$ Bn), by Route of Administration, 2023
  • Figure 03: Global Levothyroxine Market Value Share, by Route of Administration, 2023
  • Figure 04: Global Levothyroxine Market Revenue (US$ Bn), by Distribution Channel, 2023
  • Figure 05: Global Levothyroxine Market Value Share, by Distribution Channel, 2023
  • Figure 06: Global Levothyroxine Market Value Share, by Region, 2023
  • Figure 07: Global Levothyroxine Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 08: Global Levothyroxine Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 09: Global Levothyroxine Market Attractiveness Analysis, by Route of Administration, 2020-2034
  • Figure 10: Global Levothyroxine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 11: Global Levothyroxine Market Attractiveness Analysis, by Distribution Channel, 2020-2034
  • Figure 12: Global Levothyroxine Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 13: Global Levothyroxine Market Attractiveness Analysis, by Region, 2020-2034
  • Figure 14: North America Levothyroxine Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 15: North America Levothyroxine Market Attractiveness Analysis, by Country, 2020-2034
  • Figure 16: North America Levothyroxine Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 17: North America Levothyroxine Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 18: North America Levothyroxine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 19: North America Levothyroxine Market Attractiveness Analysis, by Route of Administration, 2020-2034
  • Figure 20: North America Levothyroxine Market Attractiveness Analysis, by Distribution Channel, 2020-2034
  • Figure 21: Europe Levothyroxine Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 22: Europe Levothyroxine Market Attractiveness Analysis, by Country/Sub-region, 2020-2034
  • Figure 23: Europe Levothyroxine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 24: Europe Levothyroxine Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 25: Europe Levothyroxine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 26: Europe Levothyroxine Market Attractiveness Analysis, by Route of Administration, 2020-2034
  • Figure 27: Europe Levothyroxine Market Attractiveness Analysis, by Distribution Channel, 2020-2034
  • Figure 28: Asia Pacific Levothyroxine Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 29: Asia Pacific Levothyroxine Market Attractiveness Analysis, by Country/Sub-region, 2020-2034
  • Figure 30: Asia Pacific Levothyroxine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 31: Asia Pacific Levothyroxine Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 32: Asia Pacific Levothyroxine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 33: Asia Pacific Levothyroxine Market Attractiveness Analysis, by Route of Administration, 2020-2034
  • Figure 34: Asia Pacific Levothyroxine Market Attractiveness Analysis, by Distribution Channel, 2020-2034
  • Figure 35: Latin America Levothyroxine Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 36: Latin America Levothyroxine Market Attractiveness Analysis, by Country/Sub-region, 2020-2034
  • Figure 37: Latin America Levothyroxine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 38: Latin America Levothyroxine Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 39: Latin America Levothyroxine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 40: Latin America Levothyroxine Market Attractiveness Analysis, by Route of Administration, 2020-2034
  • Figure 41: Latin America Levothyroxine Market Attractiveness Analysis, by Distribution Channel, 2020-2034
  • Figure 42: Middle East & Africa Levothyroxine Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 43: Middle East & Africa Levothyroxine Market Attractiveness Analysis, by Country/Sub-region, 2020-2034
  • Figure 44: Middle East & Africa Levothyroxine Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 45: Middle East & Africa Levothyroxine Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 46: Middle East & Africa Levothyroxine Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 47: Middle East & Africa Levothyroxine Market Attractiveness Analysis, by Route of Administration, 2020-2034
  • Figure 48: Middle East & Africa Levothyroxine Market Attractiveness Analysis, by Distribution Channel, 2020-2034
目次
Product Code: TMRGL86260

Levothyroxine Market - Scope of Report

TMR's report on the global levothyroxine market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global levothyroxine market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global levothyroxine market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the levothyroxine market.

Market Snapshot
Market Value in 2023US$ 3.8 Bn
Market Value in 2034US$ 5.4 Bn
CAGR3.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global levothyroxine market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global levothyroxine market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global levothyroxine market.

The report delves into the competitive landscape of the global levothyroxine market. Key players operating in the global levothyroxine market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global levothyroxine market profiled in this report.

Key Questions Answered in Global levothyroxine Market Report:

  • What is the sales/revenue generated by levothyroxine across all regions during the forecast period?
  • What are the opportunities in the global levothyroxine market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Levothyroxine Market - Research Objectives and Research Approach

The comprehensive report on the global levothyroxine market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global levothyroxine market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global levothyroxine market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Levothyroxine Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Levothyroxine Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Levothyroxine Market Analysis and Forecast, by Route of Administration

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Route of Administration, 2020-2034
    • 6.3.1. Oral
    • 6.3.2. Injectables
  • 6.4. Market Attractiveness Analysis, by Route of Administration

7. Global Levothyroxine Market Analysis and Forecast, by Distribution Channel

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Distribution Channel, 2020-2034
    • 7.3.1. Hospital Pharmacies
    • 7.3.2. Retail Pharmacies
    • 7.3.3. Online Pharmacies
  • 7.4. Market Attractiveness Analysis, by Distribution Channel

8. Global Levothyroxine Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region, 2020-2034
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Levothyroxine Market Analysis and Forecast

  • 9.1. Introduction
  • 9.2. Key Findings
  • 9.3. Market Value Forecast, by Route of Administration, 2020-2034
    • 9.3.1. Oral
    • 9.3.2. Injectables
  • 9.4. Market Value Forecast, by Distribution Channel, 2020-2034
    • 9.4.1. Hospital Pharmacies
    • 9.4.2. Retail Pharmacies
    • 9.4.3. Online Pharmacies
  • 9.5. Market Value Forecast, by Country, 2020-2034
    • 9.5.1. U.S.
    • 9.5.2. Canada
  • 9.6. Market Attractiveness Analysis
    • 9.6.1. By Route of Administration
    • 9.6.2. By Distribution Channel
    • 9.6.3. By Country

10. Europe Levothyroxine Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Route of Administration, 2020-2034
    • 10.3.1. Oral
    • 10.3.2. Injectables
  • 10.4. Market Value Forecast, by Distribution Channel, 2020-2034
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 10.5.1. Germany
    • 10.5.2. U.K.
    • 10.5.3. France
    • 10.5.4. Italy
    • 10.5.5. Spain
    • 10.5.6. Rest of Europe
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Route of Administration
    • 10.6.2. By Distribution Channel
    • 10.6.3. By Country/Sub-region

11. Asia Pacific Levothyroxine Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Route of Administration, 2020-2034
    • 11.3.1. Oral
    • 11.3.2. Injectables
  • 11.4. Market Value Forecast, by Distribution Channel, 2020-2034
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Retail Pharmacies
    • 11.4.3. Online Pharmacies
  • 11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.5.1. China
    • 11.5.2. Japan
    • 11.5.3. India
    • 11.5.4. Australia & New Zealand
    • 11.5.5. Rest of Asia Pacific
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Route of Administration
    • 11.6.2. By Distribution Channel
    • 11.6.3. By Country/Sub-region

12. Latin America Levothyroxine Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Route of Administration, 2020-2034
    • 12.3.1. Oral
    • 12.3.2. Injectables
  • 12.4. Market Value Forecast, by Distribution Channel, 2020-2034
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Retail Pharmacies
    • 12.4.3. Online Pharmacies
  • 12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.5.1. Brazil
    • 12.5.2. Mexico
    • 12.5.3. Rest of Latin America
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Route of Administration
    • 12.6.2. By Distribution Channel
    • 12.6.3. By Country/Sub-region

13. Middle East & Africa Levothyroxine Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Route of Administration, 2020-2034
    • 13.3.1. Oral
    • 13.3.2. Injectables
  • 13.4. Market Value Forecast, by Distribution Channel, 2020-2034
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Retail Pharmacies
    • 13.4.3. Online Pharmacies
  • 13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.5.1. GCC Countries
    • 13.5.2. South Africa
    • 13.5.3. Rest of Middle East & Africa
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Route of Administration
    • 13.6.2. By Distribution Channel
    • 13.6.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 14.2. Market Share Analysis, by Company (2023)
  • 14.3. Company Profiles
    • 14.3.1. AbbVie Inc.
      • 14.3.1.1. Company Overview
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. SWOT Analysis
      • 14.3.1.4. Financial Overview
      • 14.3.1.5. Strategic Overview
    • 14.3.2. Mylan N.V.
      • 14.3.2.1. Company Overview
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. SWOT Analysis
      • 14.3.2.4. Financial Overview
      • 14.3.2.5. Strategic Overview
    • 14.3.3. Merck & Co., Inc.
      • 14.3.3.1. Company Overview
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. SWOT Analysis
      • 14.3.3.4. Financial Overview
      • 14.3.3.5. Strategic Overview
    • 14.3.4. Pfizer Inc.
      • 14.3.4.1. Company Overview
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. SWOT Analysis
      • 14.3.4.4. Financial Overview
      • 14.3.4.5. Strategic Overview
    • 14.3.5. Lannett Company Inc
      • 14.3.5.1. Company Overview
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. SWOT Analysis
      • 14.3.5.4. Financial Overview
      • 14.3.5.5. Strategic Overview
    • 14.3.6. Novartis AG
      • 14.3.6.1. Company Overview
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. SWOT Analysis
      • 14.3.6.4. Financial Overview
      • 14.3.6.5. Strategic Overview
    • 14.3.7. Fresenius Kabi
      • 14.3.7.1. Company Overview
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. SWOT Analysis
      • 14.3.7.4. Financial Overview
      • 14.3.7.5. Strategic Overview
    • 14.3.8. Piramal Critical Care
      • 14.3.8.1. Company Overview
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. SWOT Analysis
      • 14.3.8.4. Financial Overview
      • 14.3.8.5. Strategic Overview
    • 14.3.9. Abbott Laboratories
      • 14.3.9.1. Company Overview
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. SWOT Analysis
      • 14.3.9.4. Financial Overview
      • 14.3.9.5. Strategic Overview